Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Interdisciplinary multimodality management of stage III nonsmall cell lung cancer.

Huber RM, De Ruysscher D, Hoffmann H, Reu S, Tufman A.

Eur Respir Rev. 2019 Jul 8;28(152). pii: 190024. doi: 10.1183/16000617.0024-2019. Print 2019 Jun 30. Review.

2.

Author Correction: Consistent success in life-supporting porcine cardiac xenotransplantation.

Längin M, Mayr T, Reichart B, Michel S, Buchholz S, Guethoff S, Dashkevich A, Baehr A, Egerer S, Bauer A, Mihalj M, Panelli A, Issl L, Ying J, Fresch AK, Buttgereit I, Mokelke M, Radan J, Werner F, Lutzmann I, Steen S, Sjöberg T, Paskevicius A, Qiuming L, Sfriso R, Rieben R, Dahlhoff M, Kessler B, Kemter E, Kurome M, Zakhartchenko V, Klett K, Hinkel R, Kupatt C, Falkenau A, Reu S, Ellgass R, Herzog R, Binder U, Wich G, Skerra A, Ayares D, Kind A, Schönmann U, Kaup FJ, Hagl C, Wolf E, Klymiuk N, Brenner P, Abicht JM.

Nature. 2019 Apr;568(7752):E7. doi: 10.1038/s41586-019-1108-4.

PMID:
30944481
3.

Lung disease in STAT3 hyper-IgE syndrome requires intense therapy.

Kröner C, Neumann J, Ley-Zaporozhan J, Hagl B, Meixner I, Spielberger BD, Dückers G, Belohradsky BH, Niehues T, Borte M, Rosenecker J, Kappler M, Nährig S, Reu S, Griese M, Renner ED.

Allergy. 2019 Feb 21. doi: 10.1111/all.13753. [Epub ahead of print]

PMID:
30793327
4.

Early onset children's interstitial lung diseases: Discrete entities or manifestations of pulmonary dysmaturity?

Bush A, Griese M, Seidl E, Kerem E, Reu S, Nicholson AG.

Paediatr Respir Rev. 2019 Apr;30:65-71. doi: 10.1016/j.prrv.2018.09.004. Epub 2018 Oct 9. Review.

PMID:
30552058
5.

Consistent success in life-supporting porcine cardiac xenotransplantation.

Längin M, Mayr T, Reichart B, Michel S, Buchholz S, Guethoff S, Dashkevich A, Baehr A, Egerer S, Bauer A, Mihalj M, Panelli A, Issl L, Ying J, Fresch AK, Buttgereit I, Mokelke M, Radan J, Werner F, Lutzmann I, Steen S, Sjöberg T, Paskevicius A, Qiuming L, Sfriso R, Rieben R, Dahlhoff M, Kessler B, Kemter E, Kurome M, Zakhartchenko V, Klett K, Hinkel R, Kupatt C, Falkenau A, Reu S, Ellgass R, Herzog R, Binder U, Wich G, Skerra A, Ayares D, Kind A, Schönmann U, Kaup FJ, Hagl C, Wolf E, Klymiuk N, Brenner P, Abicht JM.

Nature. 2018 Dec;564(7736):430-433. doi: 10.1038/s41586-018-0765-z. Epub 2018 Dec 5. Erratum in: Nature. 2019 Apr;568(7752):E7.

PMID:
30518863
6.

Pulmonary interstitial glycogenosis - A systematic analysis of new cases.

Seidl E, Carlens J, Reu S, Wetzke M, Ley-Zaporozhan J, Brasch F, Wesselak T, Schams A, Rauch D, Schuch L, Kappler M, Schelstraete P, Wolf M, Stehling F, Haarmann E, Borensztajn D, van de Loo M, Rubak S, Lex C, Hinrichs B, Reiter K, Schwerk N, Griese M.

Respir Med. 2018 Jul;140:11-20. doi: 10.1016/j.rmed.2018.05.009. Epub 2018 May 17. Review.

PMID:
29957271
7.

Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and Management.

Leuschner G, Reiter F, Stocker F, Crispin A, Kneidinger N, Veit T, Klenner F, Ceelen F, Zimmermann G, Leuchte H, Reu S, Dinkel J, Behr J, Neurohr C.

Lung. 2018 Aug;196(4):401-408. doi: 10.1007/s00408-018-0123-9. Epub 2018 May 14.

PMID:
29761229
8.

Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood.

Hengst M, Naehrlich L, Mahavadi P, Grosse-Onnebrink J, Terheggen-Lagro S, Skanke LH, Schuch LA, Brasch F, Guenther A, Reu S, Ley-Zaporozhan J, Griese M.

Orphanet J Rare Dis. 2018 Mar 27;13(1):42. doi: 10.1186/s13023-018-0780-z.

9.

NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor Therapy.

Kauffmann-Guerrero D, Huber RM, Reu S, Tufman A, Mertsch P, Syunyaeva Z, Jung A, Kahnert K.

Respiration. 2018;95(3):169-176. doi: 10.1159/000484175. Epub 2017 Nov 30.

10.

Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer.

Tufman A, Kahnert K, Duell T, Kauffmann-Guerrero D, Milger K, Schneider C, Stump J, Syunyaeva Z, Huber RM, Reu S.

Onco Targets Ther. 2017 Oct 25;10:5179-5186. doi: 10.2147/OTT.S140472. eCollection 2017.

11.

EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC - Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP®).

Petersen I, Dietel M, Geilenkeuser WJ, Mireskandari M, Weichert W, Steiger K, Scheel AH, Büttner R, Schirmacher P, Warth A, Lasitschka F, Schildhaus HU, Kirchner T, Reu S, Kreipe H, Länger F, Tiemann M, Schulte C, Jöhrens K.

Pathol Res Pract. 2017 Dec;213(12):1530-1535. doi: 10.1016/j.prp.2017.09.021. Epub 2017 Sep 28.

12.

International management platform for children's interstitial lung disease (chILD-EU).

Griese M, Seidl E, Hengst M, Reu S, Rock H, Anthony G, Kiper N, Emiralioğlu N, Snijders D, Goldbeck L, Leidl R, Ley-Zaporozhan J, Krüger-Stollfuss I, Kammer B, Wesselak T, Eismann C, Schams A, Neuner D, MacLean M, Nicholson AG, Lauren M, Clement A, Epaud R, de Blic J, Ashworth M, Aurora P, Calder A, Wetzke M, Kappler M, Cunningham S, Schwerk N, Bush A; the other chILD-EU collaborators.

Thorax. 2018 Mar;73(3):231-239. doi: 10.1136/thoraxjnl-2017-210519. Epub 2017 Oct 22.

13.

Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.

Schiergens TS, Renz BW, Reu S, Neumann J, Al-Sayegh R, Nieß H, Ilmer M, Kruger S, Boeck S, Heinemann V, Werner J, Kleespies A.

J Gastrointest Surg. 2017 Nov;21(11):1775-1783. doi: 10.1007/s11605-017-3489-8. Epub 2017 Sep 5.

PMID:
28875420
14.

Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer.

Scheel AH, Baenfer G, Baretton G, Dietel M, Diezko R, Henkel T, Heukamp LC, Jasani B, Jöhrens K, Kirchner T, Lasitschka F, Petersen I, Reu S, Schildhaus HU, Schirmacher P, Schwamborn K, Sommer U, Stoss O, Tiemann M, Warth A, Weichert W, Wolf J, Büttner R, Rüschoff J.

Histopathology. 2018 Feb;72(3):449-459. doi: 10.1111/his.13375. Epub 2017 Nov 21.

PMID:
28851100
15.

[Predictive PD-L1 immunohistochemistry for non-small cell lung cancer : Current state of the art and experiences of the first German harmonization study].

Scheel AH, Dietel M, Heukamp LC, Jöhrens K, Kirchner T, Reu S, Rüschoff J, Schildhaus HU, Schirmacher P, Tiemann M, Warth A, Weichert W, Fischer RN, Wolf J, Büttner R.

Pathologe. 2016 Nov;37(6):557-567. Review. German.

PMID:
27510417
16.

Lung disease caused by ABCA3 mutations.

Kröner C, Wittmann T, Reu S, Teusch V, Klemme M, Rauch D, Hengst M, Kappler M, Cobanoglu N, Sismanlar T, Aslan AT, Campo I, Proesmans M, Schaible T, Terheggen-Lagro S, Regamey N, Eber E, Seidenberg J, Schwerk N, Aslanidis C, Lohse P, Brasch F, Zarbock R, Griese M.

Thorax. 2017 Mar;72(3):213-220. doi: 10.1136/thoraxjnl-2016-208649. Epub 2016 Aug 11.

PMID:
27516224
17.

A persistent pneumothorax? 5-year follow-up after diagnosis of Swyer-James-MacLeod syndrome.

Tufman A, Winter H, Kahnert K, Reu S, Müller-Lisse U, Huber RM.

Breathe (Sheff). 2016 Jun;12(2):e55-E58. doi: 10.1183/20734735.000316.

18.

Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas.

Scheel AH, Dietel M, Heukamp LC, Jöhrens K, Kirchner T, Reu S, Rüschoff J, Schildhaus HU, Schirmacher P, Tiemann M, Warth A, Weichert W, Fischer RN, Wolf J, Buettner R.

Mod Pathol. 2016 Oct;29(10):1165-72. doi: 10.1038/modpathol.2016.117. Epub 2016 Jul 8.

19.

Tools to explore ABCA3 mutations causing interstitial lung disease.

Wittmann T, Schindlbeck U, Höppner S, Kinting S, Frixel S, Kröner C, Liebisch G, Hegermann J, Aslanidis C, Brasch F, Reu S, Lasch P, Zarbock R, Griese M.

Pediatr Pulmonol. 2016 Dec;51(12):1284-1294. doi: 10.1002/ppul.23471. Epub 2016 May 13.

PMID:
27177387
20.

Persistent Tachypnea of Infancy. Usual and Aberrant.

Rauch D, Wetzke M, Reu S, Wesselak W, Schams A, Hengst M, Kammer B, Ley-Zaporozhan J, Kappler M, Proesmans M, Lange J, Escribano A, Kerem E, Ahrens F, Brasch F, Schwerk N, Griese M; PTI (Persistent Tachypnea of Infancy) Study Group of the Kids Lung Register.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):438-47. doi: 10.1164/rccm.201508-1655OC.

21.

[Diffuse pulmonary meningotheliomatosis].

Morresi-Hauf AT, Reu S, Heiß-Neumann M, Gesierich W, Richter T, Wagner PK.

Pneumologie. 2015 Sep;69(9):553-9. doi: 10.1055/s-0034-1392437. Epub 2015 Jul 23. German.

22.

Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer.

Neumann J, Löhrs L, Albertsmeier M, Reu S, Guba M, Werner J, Kirchner T, Angele M.

Cancer Invest. 2015;33(8):354-60. doi: 10.3109/07357907.2015.1047507. Epub 2015 Jun 12.

PMID:
26068177
23.

Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater.

Schiergens TS, Reu S, Neumann J, Renz BW, Niess H, Boeck S, Heinemann V, Bruns CJ, Jauch KW, Kleespies A.

Surgery. 2015 Jul;158(1):151-61. doi: 10.1016/j.surg.2015.02.001. Epub 2015 Mar 26.

PMID:
25819575
24.

Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients.

Kröner C, Reu S, Teusch V, Schams A, Grimmelt AC, Barker M, Brand J, Gappa M, Kitz R, Kramer BW, Lange L, Lau S, Pfannenstiel C, Proesmans M, Seidenberg J, Sismanlar T, Aslan AT, Werner C, Zielen S, Zarbock R, Brasch F, Lohse P, Griese M.

Eur Respir J. 2015 Jul;46(1):197-206. doi: 10.1183/09031936.00129414. Epub 2015 Feb 5.

25.

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.

von Laffert M, Warth A, Penzel R, Schirmacher P, Kerr KM, Elmberger G, Schildhaus HU, Büttner R, Lopez-Rios F, Reu S, Kirchner T, Pauwels P, Specht K, Drecoll E, Höfler H, Aust D, Baretton G, Bubendorf L, Stallmann S, Fisseler-Eckhoff A, Soltermann A, Tischler V, Moch H, Penault-Llorca F, Hager H, Schäper F, Lenze D, Hummel M, Dietel M.

J Thorac Oncol. 2014 Nov;9(11):1685-92. doi: 10.1097/JTO.0000000000000332.

26.

High resolution compression elastography and color doppler sonography in characterization of breast fibroadenoma.

Rjosk-Dendorfer D, Reu S, Deak Z, Hetterich H, Kolben T, Reiser M, Clevert DA.

Clin Hemorheol Microcirc. 2014;58(1):115-25. doi: 10.3233/CH-141884.

PMID:
25227197
27.

Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.

Gündisch S, Slotta-Huspenina J, Verderio P, Ciniselli CM, Pizzamiglio S, Schott C, Drecoll E, Viertler C, Zatloukal K, Kap M, Riegman P, Esposito I, Specht K, Babaryka G, Asslaber M, Bodó K, den Bakker M, den Hollander J, Fend F, Neumann J, Reu S, Perren A, Langer R, Lugli A, Becker I, Richter T, Kayser G, May AM, Carneiro F, Lopes JM, Sobin L, Höfler H, Becker KF.

Virchows Arch. 2014 Nov;465(5):509-19. doi: 10.1007/s00428-014-1624-4. Epub 2014 Aug 2.

PMID:
25085759
28.

ALK expression is absent in pancreatic ductal adenocarcinoma.

Ormanns S, Assmann G, Reu S, Gallmeier E, Bader DC, Kleespies A, Haas M, Kruger S, Heinemann V, Kirchner T, Boeck S.

J Cancer Res Clin Oncol. 2014 Sep;140(9):1625-8. doi: 10.1007/s00432-014-1774-4. Epub 2014 Jul 14.

PMID:
25017418
29.

Resection of pulmonary metastases from colon and rectal cancer: factors to predict survival differ regarding to the origin of the primary tumor.

Meimarakis G, Spelsberg F, Angele M, Preissler G, Fertmann J, Crispin A, Reu S, Kalaitzis N, Stemmler M, Giessen C, Heinemann V, Stintzing S, Hatz R, Winter H.

Ann Surg Oncol. 2014 Aug;21(8):2563-72. doi: 10.1245/s10434-014-3646-1. Epub 2014 Mar 26.

PMID:
24668147
30.

Complete pathological response to neoadjuvant pemetrexed/cisplatin in combination with regional hyperthermia in a patient with sarcomatoid peritoneal mesothelioma.

Kruger S, Angele MK, Reu S, Sotlar K, Graser A, Haas M, Albertsmeier M, Stemmler HJ, Heinemann V, Lindner LH, Boeck S.

Anticancer Drugs. 2014 Aug;25(7):854-6. doi: 10.1097/CAD.0000000000000106.

PMID:
24637577
31.

Severe non-specific immune reconstitution inflammatory syndrome (IRIS) presenting with graft-versus-host disease-like colitis.

Reu S, Neumann J, Draenert R.

Infection. 2014 Jun;42(3):599-600. doi: 10.1007/s15010-014-0585-5. Epub 2014 Jan 28. No abstract available.

PMID:
24470320
32.

Preselection based on clinical characteristics in German non-small-cell lung cancer patients screened for EML4-ALK translocation.

Tufman AL, Edelmann M, Gamarra F, Reu S, Borgmeier A, Schrödl K, Zauber R, Müller-Lisse U, Huber RM.

J Thorac Oncol. 2014 Jan;9(1):109-13. doi: 10.1097/JTO.0000000000000043.

33.

Endonasal resection of early stage squamous cell carcinoma of the nasal vestibule.

Ledderose GJ, Reu S, Englhard AS, Krause E.

Eur Arch Otorhinolaryngol. 2014 May;271(5):1051-5. doi: 10.1007/s00405-013-2660-4. Epub 2013 Aug 22.

PMID:
23974332
34.

Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.

V Laffert M, Warth A, Penzel R, Schirmacher P, Jonigk D, Kreipe H, Schildhaus HU, Merkelbach-Bruse S, Büttner R, Reu S, Kerler R, Jung A, Kirchner T, Wölfel C, Petersen I, Rodriguez R, Jochum W, Bartsch H, Fisseler-Eckhoff A, Berg E, Lenze D, Dietel M, Hummel M.

Lung Cancer. 2013 Aug;81(2):200-6. doi: 10.1016/j.lungcan.2013.04.015. Epub 2013 May 10.

PMID:
23669200
35.

Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis.

Hitkova I, Yuan G, Anderl F, Gerhard M, Kirchner T, Reu S, Röcken C, Schäfer C, Schmid RM, Vogelmann R, Ebert MP, Burgermeister E.

PLoS Pathog. 2013;9(4):e1003251. doi: 10.1371/journal.ppat.1003251. Epub 2013 Apr 11.

36.

Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms.

Michler T, Storr M, Kramer J, Ochs S, Malo A, Reu S, Göke B, Schäfer C.

Am J Physiol Gastrointest Liver Physiol. 2013 Jan 15;304(2):G181-92. doi: 10.1152/ajpgi.00133.2012. Epub 2012 Nov 8.

37.

[Epithelial-myoepithelial carcinoma of the trachea. Case report and review of the literature].

Morresi-Hauf AT, Reu S, Fertl A.

Pathologe. 2013 Feb;34(1):56-64. doi: 10.1007/s00292-012-1610-z. Review. German.

PMID:
22733116
38.

Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues.

Schuster C, Malinowsky K, Liebmann S, Berg D, Wolff C, Tran K, Schott C, Reu S, Neumann J, Faber C, Höfler H, Kirchner T, Becker KF, Hlubek F.

Histopathology. 2012 May;60(6B):E37-50. doi: 10.1111/j.1365-2559.2012.04184.x. Epub 2012 Mar 6.

PMID:
22393911
39.

[Prognostic marker profiles for risk of distant metastases in colorectal cancer].

Neumann J, Reu S, Kirchner T.

Pathologe. 2012 Feb;33(1):39-44. doi: 10.1007/s00292-011-1543-y. Review. German.

PMID:
22293788
40.

[Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers].

Reu S, Neumann J, Kirchner T.

Pathologe. 2012 Feb;33(1):31-8. doi: 10.1007/s00292-011-1552-x. Review. German.

PMID:
22293787
41.

[Mucinous neoplasms of the vermiform appendix, Pseudomyxoma peritonei, and the new WHO classification].

Reu S, Neumann J, Kirchner T.

Pathologe. 2012 Feb;33(1):24-30. doi: 10.1007/s00292-011-1542-z. Review. German.

PMID:
22179200
42.

Bisphosphonate related osteonecrosis of the jaw--manifestation in a microvascular iliac bone flap.

Pautke C, Otto S, Reu S, Kolk A, Ehrenfeld M, Stürzenbaum S, Wolff KD.

Oral Oncol. 2011 May;47(5):425-9. doi: 10.1016/j.oraloncology.2011.03.022. Epub 2011 Apr 7.

PMID:
21478047
43.

Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.

Kriegl L, Neumann J, Vieth M, Greten FR, Reu S, Jung A, Kirchner T.

Mod Pathol. 2011 Jul;24(7):1015-22. doi: 10.1038/modpathol.2011.43. Epub 2011 Mar 18.

44.

Obligate basal cell component in salivary oncocytoma facilitates distinction from acinic cell carcinoma.

Weiler C, Reu S, Zengel P, Kirchner T, Ihrler S.

Pathol Res Pract. 2009;205(12):838-42. doi: 10.1016/j.prp.2009.06.019. Epub 2009 Jul 30.

PMID:
19646823
45.

The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.

Horst D, Reu S, Kriegl L, Engel J, Kirchner T, Jung A.

Cancer. 2009 May 15;115(10):2063-70. doi: 10.1002/cncr.24254.

46.

Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease.

Herbinger KH, Adjei O, Awua-Boateng NY, Nienhuis WA, Kunaa L, Siegmund V, Nitschke J, Thompson W, Klutse E, Agbenorku P, Schipf A, Reu S, Racz P, Fleischer B, Beissner M, Fleischmann E, Helfrich K, van der Werf TS, Löscher T, Bretzel G.

Clin Infect Dis. 2009 Apr 15;48(8):1055-64. doi: 10.1086/597398.

PMID:
19275499
47.

p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors.

Wassermann S, Scheel SK, Hiendlmeyer E, Palmqvist R, Horst D, Hlubek F, Haynl A, Kriegl L, Reu S, Merkel S, Brabletz T, Kirchner T, Jung A.

Gastroenterology. 2009 Jan;136(1):196-205.e2. doi: 10.1053/j.gastro.2008.09.019. Epub 2008 Sep 20.

PMID:
18951899
48.

[Development of molecular-pathologic entities of colorectal cancer].

Kirchner T, Reu S.

Pathologe. 2008 Nov;29 Suppl 2:264-9. doi: 10.1007/s00292-008-1089-9. German.

PMID:
18841367
49.

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.

Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10356-61.

50.

[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].

Brabletz T, Jung A, Dag S, Reu S, Kirchner T.

Verh Dtsch Ges Pathol. 2000;84:175-81. German.

PMID:
11217438

Supplemental Content

Support Center